Patent details

EP2608808 Title: TREATMENT FOR NEOPLASTIC DISEASES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2608808
WO Application Number:
US2011048747
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP11820492.4
WO Publication Number:
WO2012027324
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Canada (CA)
Publications:

Dates

Filing date:
23/08/2011
Grant date:
18/01/2017
EP Publication Date:
03/07/2013
WO Publication Date:
01/03/2012
Claims Translations Received Date:
Claims Translation B1 Received Date:
11/04/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
18/01/2017
EP B1 Publication Date:
18/01/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
22/08/2031
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
10/06/2024
 
 

 

Name:
XBIOTECH INC.
Address:
1055 West Hastings Street, Suite 300, V6E 2E9, Vancouver, British Columbia, Canada (CA)

Historical Applicant/holder

From:
09/03/2021
To:
10/06/2024

 

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, 19044, Horsham PA, United States of America (US)

From:
18/01/2017
To:
09/03/2021

 

Name:
XBiotech, Inc
Address:
1055 West Hastings Street, Suite 300, VANCOUVER, BC V6E 2E9, Canada (CA)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
11/04/2017
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

Name:
SIMARD, John
Address:
Austin, TX 78744, United States of America (US)

Priority

1

Priority Patent Number:
406759 P
Priority Date:
26/10/2010
Priority Country:
United States of America (US)

2

Priority Patent Number:
411183 P
Priority Date:
08/11/2010
Priority Country:
United States of America (US)

3

Priority Patent Number:
376097 P
Priority Date:
23/08/2010
Priority Country:
United States of America (US)

4

Priority Patent Number:
201161480635 P
Priority Date:
29/04/2011
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 38/17; A61K 38/20; A61K 39/395; A61P 35/00; C07K 16/24;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
24/24
Publication date:
12/06/2024
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
13/21
Publication date:
31/03/2021
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
16/17
Publication date:
19/04/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
03/17
Publication date:
18/01/2017
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201703
Publication date:
18/01/2017
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202401061A
Date Registered:
10/06/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
XBIOTECH INC.
Address:
1055 West Hastings Street, Suite 300, V6E 2E9, Vancouver, British Columbia, Canada (CA)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202100476A
Date Registered:
09/03/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, 19044, Horsham PA, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/08/2025
Annual Fee Number:
15
Annual Fee Amount:
900 Euro
Last Annual Payment Date:
26/08/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
800 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
14/04/2017 Outgoing Correspondence Letter no formal defects 1 PDF /9/4/3/5/2/0800125349/docs/ep11820492.4_0_131358l271.pdf
11/04/2017 Claims First filed claims 1 PDF /9/4/3/5/2/0800125349/docs/ep11820492.4_1_claims20170411110837438.pdf
11/04/2017 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /9/4/3/5/2/0800125349/docs/ep11820492.4_2_incomingcorrespondenceelectronic20170411110838493.pdf